GRAL is up 5.55% today. Volume is 890.7K vs a 30-day average of 1.38M (0.64x).
GRAIL, Inc. is scheduled to report earnings Wed, Nov 4, 2026. Analysts expect EPS of $-2.65 on revenue of about $45.23M. Stocks often move sharply on earnings day.
Felix Health has already announced it will offer GRAIL's Galleri multi-cancer early detection blood test to eligible adults in Ontario through virtual assessments and at-home coll…
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the third q…
GRAIL’s updated analyst fair value estimate has shifted from US$97.40 to US$131.30, which is a meaningful reset in how the stock is being framed. The change aligns with recent Str…
Morgan Stanley analyst Tejas Savant maintains GRAIL (NASDAQ:GRAL) with a Equal-Weight and raises the price target from $60 to $120.
TD Cowen analyst Dan Brennan maintains GRAIL (NASDAQ:GRAL) with a Buy and raises the price target from $88 to $180.